4 Panel Kit - AMP/COC/OXY/THC and 9 more items

The Florida Department of Corrections awarded a contract valued at $6,341.01 for the procurement of drug and substance testing kits and related diagnostic materials. The contract, identified as C6BE93, was awarded on January 27, 2026, with a completion date of March 31, 2026. The contract encompasses multiple panel-based testing kits designed to detect controlled substances and alcohol, including amphetamine, cocaine, opioids, tetrahydrocannabinol (THC), benzodiazepines, barbiturates, 3,4-methylenedioxymethamphetamine (MDMA), and buprenorphine.

The procurement consists of ten distinct line items totaling 176 units of testing products. Major components include fifty 3-panel COC/mAMP/THC kits at $31.94 each, fourteen units each of three different 4-panel configurations ranging from $43.48 to $52.92 per unit, twenty Buprenorphine kits at $24.18 each, twenty Fentanyl detection units at $29.68 each, ten EtG alcohol tests at $80.20 each, and supplementary testing materials for K-2 Spice and Flakka. The prime contractor's identity is not disclosed in the provided documentation. The materials support the Department of Corrections' substance abuse testing and monitoring operations within Florida's correctional system during the specified performance period.